Page last updated: 2024-12-08
monoacetylcadaverine
Description
monoacetylcadaverine: found in higher levels in blood of schizophrenic patients; substrate for rat liver monoamine oxidase & hog kidney diamine oxidase; RN from Vol 90, CA Chem Form Index [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
N-acetylcadaverine : An N-substituted cadaverine that is cadaverine in which one of the amino groups has been converted to the corresponding acetamide. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 189087 |
| CHEBI ID | 88824 |
| SCHEMBL ID | 346746 |
| SCHEMBL ID | 19744248 |
| MeSH ID | M0084864 |
Synonyms (22)
| Synonym |
|---|
| monoacetylcadaverine |
| acetamide, n-(5-aminopentyl)- |
| acetylcadaverine |
| n-acetylcadaverine |
| 32343-73-0 |
| n-(5-aminopentyl)acetamide |
| n-acetyl-1,5-pentanediamine |
| AKOS006342122 |
| S6187 |
| SCHEMBL346746 |
| RMOIHHAKNOFHOE-UHFFFAOYSA-N |
| mfcd19204554 |
| DTXSID30186068 |
| CHEBI:88824 |
| monoacetyl cadaverine |
| J-018709 |
| CS-6299 |
| HY-101403 |
| Q27160802 |
| F14796 |
| AS-47643 |
| SCHEMBL19744248 |
Roles (1)
| Role | Description |
|---|
| human metabolite | Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens). |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (4)
| Class | Description |
|---|
| secondary carboxamide | A carboxamide resulting from the formal condensation of a carboxylic acid with a primary amine; formula RC(=O)NHR(1). |
| primary amino compound | A compound formally derived from ammonia by replacing one hydrogen atom by an organyl group. |
| acetamides | Compounds with the general formula RNHC(=O)CH3. |
| N-substituted cadaverine | An N-substituted diamine in which the diamine is cadaverine. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (4)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.66
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 12.66 (24.57) | | Research Supply Index | 1.79 (2.92) | | Research Growth Index | 4.45 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |